Gilead Sciences - 26 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Gilead Sciences as of November 13, 2018 is 70.92.
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 74.3772 72.9878 87.4672 64.3644 70.9200 0.50%
2017 70.1287 70.9673 83.0774 61.8304 70.5648 2.97%
2016 78.8695 91.6903 96.1492 68.2421 68.5271 -27.61%
2015 98.8291 87.7449 113.3968 87.7449 94.6652 8.63%
2014 82.8160 69.5321 105.5971 60.5366 87.1439 25.51%
2013 51.8282 34.6967 69.5228 34.6459 69.4304 104.49%
2012 26.1270 19.3499 35.2884 19.3499 33.9525 79.45%
2011 18.4568 16.9092 19.9740 16.3360 18.9200 12.94%
2010 18.1529 20.0156 22.8584 14.7135 16.7520 -16.25%
2009 21.3169 24.1204 24.4070 19.1558 20.0017 -15.39%
2008 22.7357 20.9585 26.3946 17.3206 23.6396 11.15%
2007 18.2959 14.5956 22.0680 14.4986 21.2683 41.72%
2006 14.3091 12.6426 16.1211 12.4230 15.0070 23.51%
2005 9.7710 8.0270 12.8576 7.1742 12.1503 50.24%
2004 7.4363 6.7050 9.0232 5.9816 8.0871 20.08%
2003 5.9503 4.0320 8.0883 3.7327 6.7350 71.41%
2002 3.9355 3.5495 4.5890 3.0682 3.9292 3.47%
2001 2.8974 2.1417 4.1724 1.5618 3.7974 58.48%
2000 2.1767 1.6268 3.3571 1.2550 2.3962 53.22%
1999 1.5423 1.1484 2.6689 1.0328 1.5639 31.83%
1998 0.9215 1.1016 1.2495 0.5273 1.1863 7.35%
1997 0.9058 0.7078 1.3327 0.6249 1.1051 53.00%
1996 0.8193 0.9424 1.1773 0.4984 0.7223 -21.87%
1995 0.5326 0.2709 0.9317 0.2709 0.9245 236.79%
1994 0.2906 0.3467 0.4045 0.2022 0.2745 -20.82%
1993 0.4274 0.5273 0.5527 0.3106 0.3467 -37.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $91.187B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.066B 13.80
Biogen (BIIB) United States $64.253B 13.01
Celgene (CELG) United States $49.661B 9.64
Illumina (ILMN) United States $45.627B 53.15
Vertex Pharmaceuticals (VRTX) United States $44.173B 77.17
Regeneron Pharmaceuticals (REGN) United States $37.448B 19.00
Alexion Pharmaceuticals (ALXN) United States $26.459B 18.11
BioMarin Pharmaceutical (BMRN) United States $16.572B 0.00
Incyte (INCY) United States $13.377B 369.77
Seattle Genetics (SGEN) United States $8.805B 0.00
Exact Sciences (EXAS) United States $8.388B 0.00
Sarepta Therapeutics (SRPT) United States $8.074B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $8.006B 25.61
Alnylam Pharmaceuticals (ALNY) United States $6.862B 0.00
Bluebird Bio (BLUE) United States $6.541B 0.00
Bio-Techne Corp (TECH) United States $6.181B 41.75
BeiGene (BGNE) Cayman Islands $5.950B 0.00
Amarin (AMRN) Ireland $5.794B 0.00
Alkermes (ALKS) Ireland $5.392B 3470.00
Galapagos (GLPG) Belgium $5.218B 0.00
Exelixis (EXEL) United States $4.763B 13.50
Immunomedics (IMMU) United States $3.890B 0.00
Horizon Pharma Public (HZNP) Ireland $3.644B 14.99
MorphoSys AG Unsponsored ADR (MOR) Germany $3.535B 0.00
Emergent Biosolutions (EBS) United States $3.347B 28.19
Ligand Pharmaceuticals (LGND) United States $3.281B 25.28
Guardant Health (GH) United States $3.269B 0.00
Array BioPharma (ARRY) United States $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.988B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.981B 0.00
Repligen (RGEN) United States $2.864B 89.44
Genomic Health (GHDX) United States $2.855B 97.10
Blueprint Medicines (BPMC) United States $2.624B 0.00
Ascendis Pharma (ASND) Denmark $2.532B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.483B 0.00
Acceleron Pharma (XLRN) United States $2.385B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.359B 0.00
Allakos (ALLK) United States $2.351B 0.00
Akcea Therapeutics (AKCA) United States $2.327B 0.00
China Biologic Products (CBPO) China $2.321B 16.52
MyoKardia (MYOK) United States $2.255B 0.00
REGENXBIO (RGNX) United States $2.248B 30.15
Myriad Genetics (MYGN) United States $2.217B 21.97
Halozyme Therapeutics (HALO) United States $2.183B 48.71
Global Blood Therapeutics (GBT) United States $2.018B 0.00
Amicus Therapeutics (FOLD) United States $1.914B 0.00
AnaptysBio (ANAB) United States $1.889B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.877B 0.00
Reata Pharmaceuticals (RETA) United States $1.865B 0.00
Arena Pharmaceuticals (ARNA) United States $1.683B 0.00
Medicines (MDCO) United States $1.650B 0.00
Aimmune Therapeutics (AIMT) United States $1.642B 0.00
Cambrex (CBM) United States $1.636B 12.22
Innoviva (INVA) United States $1.631B 9.22
G1 THERAPEUTICS (GTHX) United States $1.609B 0.00
Denali Therapeutics (DNLI) United States $1.583B 0.00
Spark Therapeutics (ONCE) United States $1.572B 0.00
NeoGenomics (NEO) United States $1.547B 127.92
Atara Biotherapeutics (ATRA) United States $1.542B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.463B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.363B 0.00
Editas Medicine (EDIT) United States $1.348B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Mirati Therapeutics (MRTX) United States $1.249B 0.00
Myovant Sciences (MYOV) United Kingdom $1.247B 0.00
Insmed (INSM) United States $1.237B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.219B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.186B 94.25
Rubius Therapeutics (RUBY) United States $1.164B 0.00
WAVE Life Sciences (WVE) Singapore $1.163B 0.00
Cellectis (CLLS) France $1.073B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.033B 0.00
Solid Biosciences (SLDB) United States $1.024B 0.00
Retrophin (RTRX) United States $1.022B 0.00
Sangamo Therapeutics (SGMO) United States $1.017B 0.00
DBV Technologies (DBVT) France $1.010B 0.00
Audentes Therapeutics (BOLD) United States $1.007B 0.00
Intra-Cellular Therapies (ITCI) United States $0.977B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.955B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.940B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.905B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.903B 0.00
Lion Biotechnologies (IOVA) United States $0.897B 0.00
UniQure (QURE) Netherlands $0.894B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.888B 0.00
Acorda Therapeutics (ACOR) United States $0.875B 11.08
Aptinyx (APTX) United States $0.856B 0.00
Puma Biotechnology (PBYI) United States $0.844B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.841B 0.00
Fate Therapeutics (FATE) United States $0.839B 0.00
Viking Therapeutics (VKTX) United States $0.838B 0.00
Revance Therapeutics (RVNC) United States $0.837B 0.00
Apellis Pharmaceuticals (APLS) United States $0.828B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.789B 0.00
Athenex (ATNX) United States $0.778B 0.00
Clovis Oncology (CLVS) United States $0.763B 0.00
Dynavax Technologies (DVAX) United States $0.763B 0.00
Heska (HSKA) United States $0.762B 62.36
Intellia Therapeutics (NTLA) United States $0.751B 0.00
Coherus BioSciences (CHRS) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.717B 0.00
InflaRx (IFRX) Germany $0.710B 0.00
Vericel (VCEL) United States $0.695B 0.00
AVROBIO (AVRO) United States $0.678B 0.00
Novavax (NVAX) United States $0.655B 0.00
UROGEN PHARMA (URGN) Israel $0.628B 0.00
CytomX Therapeutics (CTMX) United States $0.622B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
ANI Pharmaceuticals (ANIP) United States $0.621B 11.90
Inotek Pharmaceuticals (RCKT) United States $0.612B 0.00
Gritstone Oncology (GRTS) United States $0.601B 0.00
TWIST BIOSCIENC (TWST) $0.599B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.597B 0.00
Epizyme (EPZM) United States $0.593B 0.00
Senesco Technologies (ELOX) United States $0.590B 0.00
Scholar Rock Holding (SRRK) United States $0.585B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.574B 0.00
Principia Biopharma (PRNB) United States $0.573B 0.00
AC Immune SA (ACIU) Switzerland $0.570B 0.00
ObsEva SA (OBSV) Switzerland $0.541B 0.00
Eidos Therapeutics (EIDX) United States $0.537B 0.00
Arcus Biosciences (RCUS) United States $0.533B 0.00
Arvinas (ARVN) United States $0.523B 0.00
Mesoblast (MESO) Australia $0.516B 0.00
UNITY Biotechnology (UBX) $0.508B 0.00
Anika Therapeutics (ANIK) United States $0.505B 20.91
Kezar Life Sciences (KZR) United States $0.500B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
Inovio Pharmaceuticals (INO) United States $0.450B 0.00
Replimune (REPL) United States $0.448B 0.00
Kindred Biosciences (KIN) United States $0.436B 0.00
Kura Oncology (KURA) United States $0.436B 0.00
Sinovac Biotech (SVA) China $0.434B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.430B 0.00
Zymeworks (ZYME) Canada $0.429B 0.00
PDL BioPharma (PDLI) United States $0.415B 6.76
Sorrento Therapeutics (SRNE) United States $0.407B 69.80
MediciNova (MNOV) United States $0.400B 0.00
Five Prime Therapeutics (FPRX) United States $0.398B 0.00
Stemline Therapeutics (STML) United States $0.391B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.377B 0.00
RA PHARMCTL INC (RARX) United States $0.375B 0.00
Verastem (VSTM) United States $0.375B 0.00
Abeona Therapeutics (ABEO) United States $0.370B 0.00
Zealand Pharma (ZEAL) Denmark $0.369B 0.00
Cytokineticsorporated (CYTK) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.332B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.330B 0.00
Seres Therapeutics (MCRB) United States $0.327B 0.00
ResTORbio (TORC) United States $0.317B 0.00
Merus (MRUS) Netherlands $0.313B 0.00
Krystal Biotech (KRYS) United States $0.312B 0.00
Sutro Biopharma (STRO) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
LogicBio Therapeutics (LOGC) United States $0.301B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.296B 0.00
MannKind (MNKD) United States $0.294B 0.00
Kodiak Sciences (KOD) United States $0.293B 0.00
Geron (GERN) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.292B 0.00
Liquidia Technologies (LQDA) United States $0.289B 0.00
Aduro Biotech (ADRO) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Celcuity (CELC) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Equillium (EQ) United States $0.261B 0.00
Magenta Therapeutics (MGTA) United States $0.261B 0.00
BioDelivery Sciences (BDSI) United States $0.258B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.245B 0.00
Evelo Biosciences (EVLO) United States $0.244B 0.00
GAMIDA CELL LTD (GMDA) $0.243B 0.00
Proteostasis Therapeutics (PTI) United States $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Urovant Sciences (UROV) United States $0.235B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
TOCAGEN INC (TOCA) United States $0.232B 0.00
Agenus (AGEN) United States $0.230B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Kamada (KMDA) Israel $0.223B 20.56
Corvus Pharmaceuticals (CRVS) United States $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.219B 0.00
Idera Pharmaceuticals (IDRA) United States $0.216B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.214B 0.00
BioTime (BTX) United States $0.213B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.206B 0.00
Unum Therapeutics (UMRX) United States $0.203B 0.00
Synlogic (SYBX) United States $0.197B 0.00
Intec Pharma (NTEC) Israel $0.193B 0.00
ChromaDex (CDXC) United States $0.190B 0.00
NantKwest (NK) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
ASLAN Pharmaceuticals (ASLN) Singapore $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
Cerecor (CERC) United States $0.163B 16.67
Compugen (CGEN) Israel $0.161B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.161B 0.00
Menlo Therapeutics (MNLO) United States $0.160B 0.00
PSivida (EYPT) United States $0.160B 0.00
Allena Pharmaceuticals (ALNA) United States $0.159B 0.00
Cohbar (CWBR) United States $0.159B 0.00
Pfenex (PFNX) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.146B 0.00
XBiotech (XBIT) United States $0.144B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.143B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Mersana Therapeutics (MRSN) United States $0.135B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.133B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Mustang Bio (MBIO) United States $0.125B 0.00
Cue Biopharma (CUE) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
OVID THERAPEUTC (OVID) United States $0.117B 0.00
Anavex Life Sciences (AVXL) United States $0.114B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.113B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Chiasma (CHMA) United States $0.097B 0.00
Provention Bio (PRVB) United States $0.096B 0.00
ScPharmaceuticals (SCPH) United States $0.094B 0.00
Orgenesis (ORGS) United States $0.092B 0.00
Monster Digital (INNT) United States $0.091B 0.00
Ophthotech (OPHT) United States $0.089B 0.00
VolitionRX (VNRX) Singapore $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.081B 0.00
Cel-Sci (CVM) United States $0.079B 0.00
Aptose Biosciences (APTO) Canada $0.078B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.076B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Asterias Biotherapeutics (AST) United States $0.070B 0.00
ITUS (ANIX) United States $0.068B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 68.33
Entera Bio (ENTX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.059B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.057B 9.25
Fortress Biotech (FBIO) United States $0.057B 0.00
Clearside Biomedical (CLSD) United States $0.055B 0.00
Trevena (TRVN) United States $0.055B 0.00
OncoSec Medical (ONCS) United States $0.051B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.043B 0.00
TRACON Pharmaceuticals (TCON) United States $0.041B 0.00
Galena Biopharma (SLS) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.53
Versartis (ARAV) United States $0.039B 6.39
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Celsion (CLSN) United States $0.038B 0.00
VIVUS (VVUS) United States $0.036B 0.00
GTx (GTXI) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Therapix Biosciences (TRPX) Israel $0.027B 10.21
Vical (VICL) United States $0.027B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Cellect Biotechnology (APOP) Israel $0.025B 0.00
CytRx (CYTR) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Arsanis (ASNS) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Histogenics (HSGX) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00